Does DAPAGLIFLOZIN PROPANEDIOL Cause Mobility decreased? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Mobility decreased have been filed in association with DAPAGLIFLOZIN PROPANEDIOL (FARXIGA). This represents 0.1% of all adverse event reports for DAPAGLIFLOZIN PROPANEDIOL.
20
Reports of Mobility decreased with DAPAGLIFLOZIN PROPANEDIOL
0.1%
of all DAPAGLIFLOZIN PROPANEDIOL reports
0
Deaths
7
Hospitalizations
How Dangerous Is Mobility decreased From DAPAGLIFLOZIN PROPANEDIOL?
Of the 20 reports, 7 (35.0%) required hospitalization, and 2 (10.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN PROPANEDIOL. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN PROPANEDIOL Cause?
Death (3,443)
Fungal infection (1,204)
Blood glucose increased (778)
Weight decreased (777)
Urinary tract infection (583)
Dizziness (582)
Diabetic ketoacidosis (547)
Nausea (460)
Fatigue (442)
Pollakiuria (388)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which DAPAGLIFLOZIN PROPANEDIOL Alternatives Have Lower Mobility decreased Risk?
DAPAGLIFLOZIN PROPANEDIOL vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN PROPANEDIOL vs DAPRODUSTAT
DAPAGLIFLOZIN PROPANEDIOL vs DAPSONE
DAPAGLIFLOZIN PROPANEDIOL vs DAPTOMYCIN
DAPAGLIFLOZIN PROPANEDIOL vs DARATUMUMAB